Targeted RNA interference of phosphatidylinositol 3-kinase p110-β induces apoptosis and proliferation arrest in endometrial carcinoma cells

H. J. An, N. H. Cho, H. S. Yang, K. B. Kwak, N. K. Kim, D. Y. Oh, S. W. Lee, H. O. Kim, J. J. Koh

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Phosphatidylinositol 3-kinase (PI3K) signalling plays a pivotal role in intracellular signal transduction pathways involved in cell growth, cellular transformation, and tumourigenesis. PI3K is overexpressed in many human cancers, including endometrial carcinomas, one of the most common female genital tract malignancies. Here, we used small interfering RNA (siRNA) targeted to PI3K p110-β to determine whether inhibition of the β isoform could be a potential therapeutic target for endometrial carcinoma. In this study, treatment of HEC-1B endometrial cancer cells with PI3K p110-β-specific siRNA resulted in increased apoptosis and decreased tumour cell proliferation. Depletion of PI3K p110-β decreased the protein levels of AKT1, AKT2, pAKT, and mTOR - downstream targets of PI3K. Knock-down of PI3K p110-β by siRNA also induced decreased expression of cyclin E and Bcl-2, suggesting that PI3K p110-β stimulates tumour growth, at least in part by regulating cyclin E and Bcl-2. Thus, our results indicate that siRNA-mediated gene silencing of PI3K p110-β may be a useful therapeutic strategy for endometrial cancers overexpressing PI3K p110-β.

Original languageEnglish
Pages (from-to)161-169
Number of pages9
JournalJournal of Pathology
Volume212
Issue number2
DOIs
Publication statusPublished - 2007 Jun 1

Fingerprint

Phosphatidylinositol 3-Kinase
Endometrial Neoplasms
RNA Interference
Apoptosis
Small Interfering RNA
Cyclin E
Neoplasms
Gene Silencing
Growth
Signal Transduction
Protein Isoforms
Cell Proliferation

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

An, H. J. ; Cho, N. H. ; Yang, H. S. ; Kwak, K. B. ; Kim, N. K. ; Oh, D. Y. ; Lee, S. W. ; Kim, H. O. ; Koh, J. J. / Targeted RNA interference of phosphatidylinositol 3-kinase p110-β induces apoptosis and proliferation arrest in endometrial carcinoma cells. In: Journal of Pathology. 2007 ; Vol. 212, No. 2. pp. 161-169.
@article{563d32eb08d2461089df437d8e867051,
title = "Targeted RNA interference of phosphatidylinositol 3-kinase p110-β induces apoptosis and proliferation arrest in endometrial carcinoma cells",
abstract = "Phosphatidylinositol 3-kinase (PI3K) signalling plays a pivotal role in intracellular signal transduction pathways involved in cell growth, cellular transformation, and tumourigenesis. PI3K is overexpressed in many human cancers, including endometrial carcinomas, one of the most common female genital tract malignancies. Here, we used small interfering RNA (siRNA) targeted to PI3K p110-β to determine whether inhibition of the β isoform could be a potential therapeutic target for endometrial carcinoma. In this study, treatment of HEC-1B endometrial cancer cells with PI3K p110-β-specific siRNA resulted in increased apoptosis and decreased tumour cell proliferation. Depletion of PI3K p110-β decreased the protein levels of AKT1, AKT2, pAKT, and mTOR - downstream targets of PI3K. Knock-down of PI3K p110-β by siRNA also induced decreased expression of cyclin E and Bcl-2, suggesting that PI3K p110-β stimulates tumour growth, at least in part by regulating cyclin E and Bcl-2. Thus, our results indicate that siRNA-mediated gene silencing of PI3K p110-β may be a useful therapeutic strategy for endometrial cancers overexpressing PI3K p110-β.",
author = "An, {H. J.} and Cho, {N. H.} and Yang, {H. S.} and Kwak, {K. B.} and Kim, {N. K.} and Oh, {D. Y.} and Lee, {S. W.} and Kim, {H. O.} and Koh, {J. J.}",
year = "2007",
month = "6",
day = "1",
doi = "10.1002/path.2158",
language = "English",
volume = "212",
pages = "161--169",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

Targeted RNA interference of phosphatidylinositol 3-kinase p110-β induces apoptosis and proliferation arrest in endometrial carcinoma cells. / An, H. J.; Cho, N. H.; Yang, H. S.; Kwak, K. B.; Kim, N. K.; Oh, D. Y.; Lee, S. W.; Kim, H. O.; Koh, J. J.

In: Journal of Pathology, Vol. 212, No. 2, 01.06.2007, p. 161-169.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Targeted RNA interference of phosphatidylinositol 3-kinase p110-β induces apoptosis and proliferation arrest in endometrial carcinoma cells

AU - An, H. J.

AU - Cho, N. H.

AU - Yang, H. S.

AU - Kwak, K. B.

AU - Kim, N. K.

AU - Oh, D. Y.

AU - Lee, S. W.

AU - Kim, H. O.

AU - Koh, J. J.

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Phosphatidylinositol 3-kinase (PI3K) signalling plays a pivotal role in intracellular signal transduction pathways involved in cell growth, cellular transformation, and tumourigenesis. PI3K is overexpressed in many human cancers, including endometrial carcinomas, one of the most common female genital tract malignancies. Here, we used small interfering RNA (siRNA) targeted to PI3K p110-β to determine whether inhibition of the β isoform could be a potential therapeutic target for endometrial carcinoma. In this study, treatment of HEC-1B endometrial cancer cells with PI3K p110-β-specific siRNA resulted in increased apoptosis and decreased tumour cell proliferation. Depletion of PI3K p110-β decreased the protein levels of AKT1, AKT2, pAKT, and mTOR - downstream targets of PI3K. Knock-down of PI3K p110-β by siRNA also induced decreased expression of cyclin E and Bcl-2, suggesting that PI3K p110-β stimulates tumour growth, at least in part by regulating cyclin E and Bcl-2. Thus, our results indicate that siRNA-mediated gene silencing of PI3K p110-β may be a useful therapeutic strategy for endometrial cancers overexpressing PI3K p110-β.

AB - Phosphatidylinositol 3-kinase (PI3K) signalling plays a pivotal role in intracellular signal transduction pathways involved in cell growth, cellular transformation, and tumourigenesis. PI3K is overexpressed in many human cancers, including endometrial carcinomas, one of the most common female genital tract malignancies. Here, we used small interfering RNA (siRNA) targeted to PI3K p110-β to determine whether inhibition of the β isoform could be a potential therapeutic target for endometrial carcinoma. In this study, treatment of HEC-1B endometrial cancer cells with PI3K p110-β-specific siRNA resulted in increased apoptosis and decreased tumour cell proliferation. Depletion of PI3K p110-β decreased the protein levels of AKT1, AKT2, pAKT, and mTOR - downstream targets of PI3K. Knock-down of PI3K p110-β by siRNA also induced decreased expression of cyclin E and Bcl-2, suggesting that PI3K p110-β stimulates tumour growth, at least in part by regulating cyclin E and Bcl-2. Thus, our results indicate that siRNA-mediated gene silencing of PI3K p110-β may be a useful therapeutic strategy for endometrial cancers overexpressing PI3K p110-β.

UR - http://www.scopus.com/inward/record.url?scp=34249819647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249819647&partnerID=8YFLogxK

U2 - 10.1002/path.2158

DO - 10.1002/path.2158

M3 - Article

C2 - 17427168

AN - SCOPUS:34249819647

VL - 212

SP - 161

EP - 169

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 2

ER -